Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States

• 2022

  Log in to bookmark this resource.

  Log in
• Gabriela Gomez; Christopher Nelson; Christopher Rizzo; Donald Shepard; Sandra Chaves
PMID: 35968865DOI: https://doi.org/10.1093/infdis/jiac164

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This article is about a study on the health effects of different ways to pay for nirsevimab in the United States. Nirsevimab is a medicine used to prevent respiratory infections in babies. The study looks at how these payment methods can affect health outcomes and whether they create unfair differences among people. It describes how some groups might have better access to this medicine than others, leading to unequal health benefits. The goal is to find fairer ways for everyone, especially vulnerable groups like infants, to get important medicines like nirsevimab without facing barriers due to cost or availability.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Infant; Reimbursement Mechanisms; Respiratory Syncytial Virus Infections; United States; Respiratory Syncytial Virus, Human; Antibodies, Monoclonal, Humanized

Institutions: Sanofi; London School of Hygiene and Tropical Medicine; Brandeis University; London School of Hygiene & Tropical Medicine

---

More like this

The Respiratory Syncytial Virus Vaccine and Monoclonal Antibody Landscape: The Road to Global Access 2024 · University Medical Center Utrecht, Yenepoya University, University of Edinburgh, National Institutes of Health (NIH), London School of Hygiene and Tropical Medicine, London School of Hygiene & Tropical Medicine Development of a Pediatric Ebola Predictive Score, Sierra Leone 2018 · University College London, Save the Children, London School of Hygiene & Tropical Medicine Paediatric Emergency Triage, Assessment and Treatment (ETAT) – Preparedness for Implementation at Primary Care Facilities in Malawi 2021 · Karolinska Institutet, University of Malawi, University College London, Malawi Epidemiology and Intervention Research Unit, Parent and Child Health Initiative Trust, Liverpool School of Tropical Medicine

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---